SalaryGuide
AboutPricingFor Employers

Marketing jobs

3 marketing jobs

PolyNovo Limited logo
3 weeks ago

Senior Director, Marketing

PolyNovo Limited

Carlsbad, CA (On-site)Full time$200K/yr – $230K/yr
PolyNovo Limited logo
5 weeks ago

Vice President Marketing

PolyNovo Limited

Carlsbad, CA (On-site)Full time$250K/yr – $290K/yr
PolyNovo Limited logo
5 weeks ago

Marketing Specialist

PolyNovo Limited

Carlsbad, CA (Hybrid)Full time$80K/yr – $90K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

3 jobs
PolyNovo Limited logo

Senior Director, Marketing

PolyNovo Limited

Carlsbad, CA (On-site)

$200K/yr - $230K/yrIn-houseFull-timeSenior level
3 weeks ago
PolyNovo Limited logo

Vice President Marketing

PolyNovo Limited

Carlsbad, CA (On-site)

$250K/yr - $290K/yrIn-houseFull-timeSenior level
5 weeks ago
PolyNovo Limited logo

Marketing Specialist

PolyNovo Limited

Carlsbad, CA (Hybrid)

$80K/yr - $90K/yrIn-houseFull-timeMid level4+ years exp.
5 weeks ago
PolyNovo Limited logo
PolyNovo Limited

Senior Director, Marketing

Carlsbad, CA (On-site)

$200K/yr – $230K/yrSenior LevelFull time

Posted 3 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own global marketing strategy and portfolio lifecycle, align with board objectives, and drive launches, pricing, and compliance to inform executive decisions.

  • Growth leadership: Lead global marketing, brand, and corporate communications strategies aligned with Board objectives.
  • Market positioning and demand: Strengthen global positioning, drive demand generation and adoption velocity with Sales.
  • Portfolio and lifecycle ownership: Own portfolio strategy and lifecycle management to maximize adoption and long term value.

Job Description

Own global marketing strategy and portfolio lifecycle, align with board objectives, and drive launches, pricing, and compliance to inform executive decisions.

  • Growth leadership: Lead the development and execution of global marketing, brand, and corporate communications strategies aligned with Board objectives.
  • Market positioning and demand: Strengthen global positioning, drive demand generation and adoption velocity in partnership with Sales.
  • Portfolio and lifecycle ownership: Own global portfolio strategy and lifecycle management to maximize product adoption and long term value.
  • Launch and readiness: Oversee global product launch planning and commercial readiness for new products, indications, and geographies.
  • Pricing and value: Establish and govern pricing, value, and reimbursement strategies to support sustainable expansion.
  • Competitive intelligence: Lead global market, customer, and competitive intelligence to inform executive and Board decisions.
  • Digital and omnichannel: Own the global digital, data, and omnichannel marketing strategy for compliant healthcare professional engagement.
  • Operating model: Define and govern the global marketing operating model balancing global strategy with regional execution.
  • People and partnerships: Build and lead a high performing global marketing and communications organization and manage agencies and budgets.
PolyNovo Limited logo

PolyNovo Limited

3.1 Glassdoor

PolyNovo is a disruptive medical technology company. Its products simplify managing acute complex wounds, redefining healing with differentiated outcomes across many etiologies. After treating 80,000+ patients across 46 countries, the company is investing for growth via new products, indications and markets with a view to treat millions more. Our registered address is 2/320 Lorimer St, Port Melbourne, Victoria 3207, Australia.

Founded in 1998
Port Melbourne, Victoria, AUS
292 employees (13 in marketing)
polynovo.com
55% recommend to a friend

Traffic Signals

Monthly Visitors
14.5K
Traffic Source Mix
Search
45%
Direct
34.5%
Referral
11.1%
Social
8%
Paid
1.2%

Headcount Trend

Current headcount: ~292

Marketing Team

Marketing Team Size
12 (4% of company)
Median Career Experience
15 years
Median Tenure
2.2 years
Marketing Roles Posted (Last 30 Days)
3

People

Founders / CEO

Bruce Peatey
Chief Executive Officer
At the company for 8 months

HR / Recruitment

Kimberley Axon
Kimberley Axon
Chief People Officer
At the company for 1 year 5 months

Marketing Leadership

TJ Quigley
TJ Quigley
Senior Director of Marketing
At the company for 1 year 10 months
Haley Schneider
Haley Schneider
Senior Product Marketing Manager
At the company for 2 years 10 months

Recent News

PolyNovo Appoints New Company Secretary and General Counsel
Dec 8, 2025 • TipRanks
PolyNovo Highlights Industry Position at Bell Potter Healthcare Conference
Nov 17, 2025 • TipRanks
Brand new chair but same old obfuscation at PolyNovo
Oct 28, 2025 • The Australian
ASX 200 LIVE: ASX to rise; PolyNovo jumps after chairman David Williams resigns
Oct 27, 2025 • AFR
PolyNovo AGM Results: Key Resolutions Passed
Oct 27, 2025 • TipRanks
Leadership change at PolyNovo as long-time Chair steps down
Oct 27, 2025 • BiotechDispatch
PolyNovo Chairman David Williams Steps Down
Oct 27, 2025 • Sharecafe
PolyNovo welcomes Bruce Peatey as CEO
Oct 22, 2025 • Pharmafile
PolyNovo (ASX:PNV): Valuation Perspectives Following Board Appointment of ResMed Veteran Robert Douglas
Oct 20, 2025 • Yahoo Finance
Will PolyNovo’s (ASX:PNV) New Board Addition Shape Its U.S. Medtech Strategy?
Oct 19, 2025 • Yahoo Finance
Polynovo Limited Appoints New Director to Strengthen Leadership
Oct 19, 2025 • TipRanks
PolyNovo (ASX:PNV) Valuation in Focus After Board Appointment of ResMed Veteran Robert Douglas
Oct 18, 2025 • simplywall.st
Is Weakness In PolyNovo Limited (ASX:PNV) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Oct 17, 2025 • simplywall.st
ALERT: Price-sensitive ASX Announcement for PNV
Oct 16, 2025 • intelligentinvestor.com.au
PolyNovo Appoints New Chief Executive Officer
Oct 16, 2025 • Sharecafe
PolyNovo Appoints Bruce Peatey as CEO to Drive Global Expansion
Oct 15, 2025 • TipRanks
PolyNovo Appoints Robert Douglas as Non-Executive Director
Oct 13, 2025 • TipRanks
PolyNovo (ASX:PNV) FY25 Revenue Increased 23%, EBITDA Increased 211%
Oct 8, 2025 • Kalkine Media
PolyNovo shares jump after dismissal of pharma tariffs
Sep 30, 2025 • Capital Brief
At AU$1.38, Is PolyNovo Limited (ASX:PNV) Worth Looking At Closely?
Sep 28, 2025 • simplywall.st
Citigroup Ceases to be Substantial Holder in Polynovo
Sep 18, 2025 • TipRanks
PolyNovo Director Increases Stake with Share Acquisition
Sep 17, 2025 • TipRanks
Polynovo Director Increases Shareholding, Signaling Confidence
Sep 15, 2025 • TipRanks
PolyNovo (PNV AU): Solid FY25 Performance; Label and Geography Expansion to Accelerate Growth
Sep 14, 2025 • Smartkarma
PolyNovo says chronic wound treatment more effective than clinical standard alone
Sep 12, 2025 • Capital Brief
ALERT: Price-sensitive ASX Announcement for PNV
Sep 12, 2025 • intelligentinvestor.com.au
PolyNovo Initiates Trading Halt Ahead of Clinical Trial Announcement
Sep 11, 2025 • TipRanks
PolyNovo Chairman Increases Stake in Company
Sep 11, 2025 • Finance News Network
PolyNovo Limited (ASX:PNV) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Sep 11, 2025 • simplywall.st
PolyNovo chair adds to shareholding with fresh buy
Sep 11, 2025 • Proactive financial news
PolyNovo Chairman Increases Stake in Company
Sep 11, 2025 • Sharecafe
Polynovo Director Increases Shareholding
Sep 10, 2025 • TipRanks
PolyNovo (ASX:PNV) Valuation in Focus After Strong Revenue and Profit Growth
Sep 8, 2025 • simplywall.st
PolyNovo (ASX:PNV) Valuation in Focus Following Surge in Revenue and Earnings in Latest Full Year Results
Sep 8, 2025 • Yahoo Finance
PolyNovo (ASX:PNV) Is Up 16.0% After Doubling Earnings Per Share - Has The Bull Case Changed?
Sep 6, 2025 • Yahoo Finance
Why PolyNovo (ASX:PNV) Is Up 14.6% After Reporting Strong Annual Profit and Revenue Growth
Sep 3, 2025 • simplywall.st
PolyNovo Poised to Benefit from Proposed U.S. Medicare Reimbursement Changes
Sep 2, 2025 • Sharecafe
UBS Group AG Ceases Substantial Holding in Polynovo
Sep 2, 2025 • TipRanks
Health Check: Polynovo shares go crackers after positive US reimbursement changes
Sep 2, 2025 • Stockhead
PolyNovo Shares Soar on US Medicare Changes
Sep 2, 2025 • Finance News Network
PolyNovo stock rises amid changes in Medicare reimbursements
Sep 2, 2025 • ig.com
PolyNovo set to benefit from proposed US medicare changes
Sep 2, 2025 • Capital Brief
Polynovo shares surge on growth potential from US medicare overhaul
Sep 2, 2025 • Investing.com
ASX 200 news from Tuesday 2nd September 2025: ASX falls for third day before GDP; Collins Foods, PolyNovo soar
Sep 2, 2025 • AFR
PolyNovo Requests Trading Halt Amid Speculation
Sep 1, 2025 • Sharecafe
PolyNovo in trading halt ahead of response to US health spend crackdown
Sep 1, 2025 • Capital Brief
PolyNovo Requests Trading Halt Amid Speculation on U.S. Reimbursement Changes
Aug 31, 2025 • TipRanks
PolyNovo Limited Just Recorded A 99% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 27, 2025 • Yahoo Finance
Macquarie is tipping a 66% return for this healthcare stock
Aug 26, 2025 • The Motley Fool Australia
PolyNovo Achieves Record Sales Growth in FY25, Net Profit Soars 151%
Aug 25, 2025 • Finance News Network
PolyNovo Achieves Record Sales Growth in FY25, Net Profit Soars 151%
Aug 25, 2025 • Sharecafe
PolyNovo (ASX: PNV) Charts Next Phase of Growth with New Manufacturing Investments and Broader Market Reach
Aug 21, 2025 • Kalkine Media
The past year for PolyNovo (ASX:PNV) investors has not been profitable
Aug 13, 2025 • Yahoo Finance
Why Boss Energy, DroneShield, Pilbara Minerals, and Polynovo shares are charging higher today
Jul 30, 2025 • MSN
Are PolyNovo Limited's (ASX:PNV) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Jul 13, 2025 • Yahoo Finance
NovoSorb Biodegradable Temporizing Matrix (PolyNovo) for Aesthetic Nasal Reconstruction: A Case Report of Rhinophyma Resurfacing
Jul 10, 2025 • Cureus
Deep Partial-Thickness Thermal Burns Global Market Expecting To Reach $1.76 Billion By 2029
Jul 1, 2025 • EIN Presswire
What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?
Jun 17, 2025 • Yahoo Finance
Bioengineered Artificial Skin Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
Jun 13, 2025 • EIN Presswire
‘Burdensome’: PolyNovo Chair slams ASX governance rules
May 17, 2025 • Sky News Australia
PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes
May 14, 2025 • Biotech Dispatch
Health Check: To chagrin of short sellers, Polynovo shares soar on type 1 diabetes breakthrough
May 13, 2025 • Stockhead
PolyNovo shares soar after successful human study
May 13, 2025 • Capital Brief
Polynovo shares soar on type 1 diabetes breakthrough
May 13, 2025 • The Advertiser
PolyNovo announces TGA clearance for NovoSorb MTX and enters trading halt
May 12, 2025 • Biotech Dispatch
Morgans Maintains POLYNOVO LIMITED(CALZF.US) With Buy Rating, Cuts Target Price to $1.08
May 12, 2025 • 富途牛牛
PolyNovo Sales Surge to Record Highs
Apr 9, 2025 • Sharecafe
Australian medical devices maker PolyNovo resumes slide on tariff fears
Apr 9, 2025 • Reuters
Both individual investors who control a good portion of PolyNovo Limited (ASX:PNV) along with institutions must be dismayed after last week's 11% decrease
Apr 3, 2025 • simplywall.st
PolyNovo a little fast and loose with its ASX facts
Mar 28, 2025 • The Australian
PolyNovo CEO Steps Down Amid Turmoil
Mar 11, 2025 • Sharecafe
Health Check: Poly oh no! Polynovo shares resume slide as CEO goes
Mar 11, 2025 • Stockhead
PolyNovo announces chief executive change
Mar 11, 2025 • Biotech Dispatch
Australia shares touch a 7-month low dragged by banks; Qantas slips on ex-dividend
Mar 11, 2025 • Brecorder
PolyNovo CEO Resigns After Reports of Board Tensions
Mar 10, 2025 • Bloomberg.com
PolyNovo Announces CEO Change and Strategic Leadership Transition
Mar 10, 2025 • TipRanks
PolyNovo shares dive on public mea culpa
Mar 7, 2025 • The Australian
PolyNovo CEO Exit Amid Bullying Allegations
Mar 7, 2025 • Sharecafe
PolyNovo made quiet cash offer to oust CEO who made bullying claims
Mar 6, 2025 • The Australian
Spectral AI Expands DeepView® System Installations in Australia with PolyNovo Partnership
Mar 6, 2025 • Nasdaq
Australia’s PolyNovo hits 16-month low after CEO asked to step down
Mar 6, 2025 • Investing.com
PolyNovo chair pushed to resign after secret bullying investigation
Mar 5, 2025 • The Australian
PolyNovo (ASX:PNV) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Mar 3, 2025 • simplywall.st
PolyNovo posts record half-year revenue as sales surge 28%
Feb 24, 2025 • Finance News Network
Skin in the game: PolyNovo soars on monthly sales rise
Dec 23, 2024 • The Australian
PolyNovo to exhibit at MEDICA 2024 with Medilink UK
Oct 29, 2024 • Med-Tech Innovation
Spectral AI, PolyNovo Team Up to Deploy DeepView System in Australia
Aug 20, 2024 • Medical Product Outsourcing
Spectral AI collaborates with Polynovo to test wound healing device
Jul 12, 2024 • http://www.zdnet.com/
At AU$2.45, Is It Time To Put PolyNovo Limited (ASX:PNV) On Your Watch List?
Jul 5, 2024 • Yahoo Finance
Australia's PolyNovo jumps most in over 5 months on robust sales, revenue
Dec 6, 2023 • TradingView
Polynovo Says Total Group Revenue For November Including BARDA Was A$9.5 Mln
Dec 6, 2023 • TradingView
Morningstar starts coverage of Australia's Polynovo, says shares appear overvalued
Sep 26, 2023 • TradingView
Wound-Treatment Specialist PolyNovo's Shares Jump on Strong August Sales
Sep 25, 2023 • MarketWatch
PolyNovo in $47m equity raising; Mac, Bells on the ticket
Nov 22, 2022 • Australian Financial Review
PolyNovo set for FDA clearance of new US product
Sep 16, 2022 • Australian Financial Review
Shares rise; Bega soars, PolyNovo, Macquarie Telecom sink
Aug 26, 2022 • Australian Financial Review
PolyNovo shares slide 18pc after earnings miss
Aug 26, 2022 • Australian Financial Review
PolyNovo soars after snaring J&J veteran as new CEO
Jul 29, 2022 • Australian Financial Review
PolyNovo to launch NovoSorb BTM at Arab Health
Jan 19, 2022 • Med-Tech Innovation